Abstract
HIV infection among AIDS patients is associated with dysfunctions in the central nervous system (CNS) at the late stages of the disease. HIV Tat protein is released extracellularly from the productively infected cells and play important role in successful HIV replication and activates the neighboring uninfected cells in the bystander fashion. The structural flexibility of Tat protein is one of the unique features, responsible for the diverse functions. The RNA binding ability and interacting domains are very important characteristic of the HIV-Tat protein. HIV Tat protein adversely affects the integrity of the blood brain barrier by a variety of mechanisms. Such compromise in the integrity of the blood brain barrier could affect the neuro-immune interactions within the brain, which results to the neuroinflammation.
Keywords: NeuroAIDS, HIV Tat and Blood Brain Barrier, MicroRNA and Blood Brain Barrier.
Current HIV Research
Title:Overview on the Tricks of HIV Tat to Hit the Blood Brain Barrier
Volume: 14 Issue: 5
Author(s): Sunit K. Singh
Affiliation:
Keywords: NeuroAIDS, HIV Tat and Blood Brain Barrier, MicroRNA and Blood Brain Barrier.
Abstract: HIV infection among AIDS patients is associated with dysfunctions in the central nervous system (CNS) at the late stages of the disease. HIV Tat protein is released extracellularly from the productively infected cells and play important role in successful HIV replication and activates the neighboring uninfected cells in the bystander fashion. The structural flexibility of Tat protein is one of the unique features, responsible for the diverse functions. The RNA binding ability and interacting domains are very important characteristic of the HIV-Tat protein. HIV Tat protein adversely affects the integrity of the blood brain barrier by a variety of mechanisms. Such compromise in the integrity of the blood brain barrier could affect the neuro-immune interactions within the brain, which results to the neuroinflammation.
Export Options
About this article
Cite this article as:
Singh K. Sunit, Overview on the Tricks of HIV Tat to Hit the Blood Brain Barrier, Current HIV Research 2016; 14 (5) . https://dx.doi.org/10.2174/1570162X14666161006111153
DOI https://dx.doi.org/10.2174/1570162X14666161006111153 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
HIV vaccine development
The development of a safe and effective vaccine that impedes HIV-1 transmission and/or limits the severity of infection remains a public health priority. The HIV-1/AIDS pandemic continues to have a disproportionate impact on vulnerable and under-served communities in the USA and globally. In the USA, minority communities that have relatively ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Current Cancer Drug Targets The Use of Lentinan for Treating Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry Chromosome 17 in Fronto Temporal Lobak Degeneration (FTLD): From MAPT to Progranulin and Back
Current Alzheimer Research Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications
Current Pharmaceutical Design The GP120 Molecule of HIV-1 and its Interaction with T Cells
Current Medicinal Chemistry Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus
Current Gene Therapy Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
Current Cancer Drug Targets Reverse Pharmacognosy: Application of Selnergy, a New Tool for Lead Discovery. The Example of ε-Viniferin
Current Drug Discovery Technologies The Regulation of E3 Ubiquitin Ligases Cbl and its Cross-talking in Bone Homeostasis
Current Stem Cell Research & Therapy Applications of Nanosystems to Anticancer Drug Therapy (Part II. Dendrimers, Micelles, Lipid-based Nanosystems)
Recent Patents on Anti-Cancer Drug Discovery Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat
Current Drug Targets Scope of Nanotechnology-based Radiation Therapy and Thermotherapy Methods in Cancer Treatment
Current Cancer Drug Targets Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease
Current Pharmaceutical Design ThermoTRP Channels in Nociceptors: Taking a Lead from Capsaicin Receptor TRPV1
Current Neuropharmacology Mesothelioma - Update on Management
Current Respiratory Medicine Reviews Low Molecular Weight and Oligomeric Chitosans and Their Bioactivities
Current Topics in Medicinal Chemistry Cell Cycle as a Target of Antineoplastic Drugs
Current Pharmaceutical Design Diagnosis and Management of Endocrine Hypertension in Children and Adolescents
Current Pharmaceutical Design Notch Signaling in Leukemias and Lymphomas
Current Molecular Medicine Antiproliferative Effects of Molecular Iodine in Cancers
Current Chemical Biology